BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16416025)

  • 1. Clostridial neurotoxins: structure-function led design of new therapeutics.
    Chaddock JA; Marks PM
    Cell Mol Life Sci; 2006 Mar; 63(5):540-51. PubMed ID: 16416025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.
    Turton K; Chaddock JA; Acharya KR
    Trends Biochem Sci; 2002 Nov; 27(11):552-8. PubMed ID: 12417130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin: structure and pharmacology.
    Hambleton P
    Eur Arch Otorhinolaryngol; 1994 Dec; ():S200-2. PubMed ID: 10774350
    [No Abstract]   [Full Text] [Related]  

  • 4. Engineered toxins: new therapeutics.
    Foster KA
    Toxicon; 2009 Oct; 54(5):587-92. PubMed ID: 19264086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the evolutionary origins of clostridial neurotoxins from analysis of the Clostridium botulinum strain A neurotoxin gene cluster.
    Doxey AC; Lynch MD; Müller KM; Meiering EM; McConkey BJ
    BMC Evol Biol; 2008 Nov; 8():316. PubMed ID: 19014598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Q Rev Biophys; 1995 Nov; 28(4):423-72. PubMed ID: 8771234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterisation of tetanus and botulinum neurotoxins binding domains.
    Lalli G; Herreros J; Osborne SL; Montecucco C; Rossetto O; Schiavo G
    J Cell Sci; 1999 Aug; 112 ( Pt 16)():2715-24. PubMed ID: 10413679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic discovery of a toxin family in Chryseobacterium piperi with sequence similarity to botulinum neurotoxins.
    Mansfield MJ; Wentz TG; Zhang S; Lee EJ; Dong M; Sharma SK; Doxey AC
    Sci Rep; 2019 Feb; 9(1):1634. PubMed ID: 30733520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming the domain structure of botulinum neurotoxins into novel therapeutics.
    Chaddock J
    Curr Top Microbiol Immunol; 2013; 364():287-306. PubMed ID: 23239358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip.
    Tehran DA; Pirazzini M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-engineering the target specificity of Clostridial neurotoxins - a route to novel therapeutics.
    Foster KA; Adams EJ; Durose L; Cruttwell CJ; Marks E; Shone CC; Chaddock JA; Cox CL; Heaton C; Sutton JM; Wayne J; Alexander FC; Rogers DF
    Neurotox Res; 2006 Apr; 9(2-3):101-7. PubMed ID: 16785105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin - from laboratory to bedside.
    Foster KA; Bigalke H; Aoki KR
    Neurotox Res; 2006 Apr; 9(2-3):133-40. PubMed ID: 16785110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics.
    Foster KA
    Drug Discov Today; 2005 Apr; 10(8):563-9. PubMed ID: 15837599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered botulinum neurotoxins as new therapeutics.
    Masuyer G; Chaddock JA; Foster KA; Acharya KR
    Annu Rev Pharmacol Toxicol; 2014; 54():27-51. PubMed ID: 24016211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin as a therapeutic agent.
    Tsui JK
    Pharmacol Ther; 1996; 72(1):13-24. PubMed ID: 8981568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action mechanisms of botulinum neurotoxins and tetanus neurotoxins].
    Deloye F; Doussau F; Poulain B
    C R Seances Soc Biol Fil; 1997; 191(3):433-50. PubMed ID: 9295967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.